The study included 30 participants between the ages 50-78, all overweight or obese (a cancer risk) yet healthy otherwise.

A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...

Jazz Pharmaceuticals plc looks very undervalued at 2.4x sales as oncology catalysts (Ziihera, Zepzelca, Epidiolex) drive ...

HOUSTON, JANUARY 9, 2026 ― At The University of Texas MD Anderson Cancer Center , research breakthroughs are made possible through seamless ...

Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...

Molly Shoichet always wanted to be a doctor – until she made her first polymer. “I thought that was the coolest thing,” says ...

Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured ...

Alzheimer’s disease has long been the nightmare diagnosis that medicine could slow at best, not stop. Now a wave of ...

Researchers found in mice that multiple nutrients and cancer cell characteristics work together to control the spread of ...

Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...

Breast cancer can spread—or metastasize—to many different parts of the body, but it's not well understood why tumors grow better in some organs than others.